<SEC-DOCUMENT>0001104659-22-058009.txt : 20220510
<SEC-HEADER>0001104659-22-058009.hdr.sgml : 20220510
<ACCEPTANCE-DATETIME>20220510091851
ACCESSION NUMBER:		0001104659-22-058009
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220510
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220510
DATE AS OF CHANGE:		20220510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		22907633

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2215025d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:syn="http://syntheticbiologics.com/20220510">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_syn_syntheticbiologics.com_20220510 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20220510_20220510 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000894158 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityCentralIndexKey">0000894158</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="syn-20220510.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-10to2022-05-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894158</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-10</xbrli:startDate>
        <xbrli:endDate>2022-05-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90B_edei--DocumentType_c20220510__20220510_zSBpYj8zVcP8"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20220510__20220510_zxNnO5Ubkhr4"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 10, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityRegistrantName_c20220510__20220510_ze2EkGszuAxl"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityRegistrantName">SYNTHETIC BIOLOGICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20220510__20220510_z5A3d1K0JxB2"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 34%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20220510__20220510_zkJOpQbiUwx2"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityFileNumber">001-12584</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20220510__20220510_z7o9LSjpwoUc"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityTaxIdentificationNumber">13-3808303</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation)</p></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">(Commission File No.)</span></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20220510__20220510_zJZCZoKsOtx1"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityAddressAddressLine1">9605 Medical Center Drive</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20220510__20220510_zypsze7nqysi"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityAddressAddressLine2">Suite 270</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressCityOrTown_c20220510__20220510_zgfo8tmEP22h"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityAddressCityOrTown">Rockville</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20220510__20220510_z2OHlTTKd2re"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Maryland</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20220510__20220510_zhym0tBHgrr3"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:EntityAddressPostalZipCode">20850</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices and zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_908_edei--CityAreaCode_c20220510__20220510_zPV7J1CXfpVf"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:CityAreaCode">301</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20220510__20220510_zB7ZeJBbX9t2"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:LocalPhoneNumber">417-4364</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_903_edei--WrittenCommunications_c20220510__20220510_zRRkWqw3456l"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20220510__20220510_zAYws1WJ1En9"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20220510__20220510_zyuUynFBAcle"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20220510__20220510_zoJpRyaJrsUb"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 33%; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 33%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20220510__20220510_zxKqvjbUZjRj"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:Security12bTitle">Common stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20220510__20220510_zMQU0iwVfJka"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" name="dei:TradingSymbol">SYN</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--SecurityExchangeName_c20220510__20220510_zRly3uBYgGD4"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NYSE American LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20220510__20220510_zRvZAUckkakb"><ix:nonNumeric contextRef="From2022-05-10to2022-05-10" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by checkmark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Item 7.01.</b></span>&#160;&#160;&#160;<b>Regulation
FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">On
May 10, 2022, Synthetic Biologics, Inc. (the &#8220;Company&#8221;) issued a press release announcing </span>positive safety data from
its Phase 1, placebo-controlled, double-blind multiple ascending dose (MAD) clinical trial of SYN-020 intestinal alkaline phosphatase
(IAP). The Phase 1 MAD study enrolled 32 healthy adult volunteers into four cohorts with SYN-020 administered orally in doses ranging
from 5 mg to 75 mg twice daily for 14 days with a follow-up evaluation at day 35. Each cohort included six subjects who received SYN-020
and two who received placebo. Analyses of preliminary data demonstrated that SYN-020 maintained a favorable safety profile and was well-tolerated
across all dose levels. There were a few treatment-related adverse events, and all were mild (grade 1) and resolved without medical intervention.
The most common adverse event, constipation, occurred in three out of 24 subjects in the treatment arm and in one out of eight subjects
in the placebo arm. No adverse event led to discontinuation of the study drug and there were no serious adverse events.&#160;SYN-020 levels
were below the limit of quantitation in all plasma samples at all timepoints during the study.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information in this
Item 7.01 and in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section
or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended and shall not be incorporated by reference into any filing with
the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The press release furnished
as Exhibit 99.1 to this Current Report on Form 8-K includes &#8220;safe harbor&#8221; language pursuant to the Private Securities Litigation
Reform Act of 1995, as amended, indicating that certain statements contained therein are &#8220;forward-looking&#8221; rather than historical.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Item
8.01.</b></span>&#160;&#160;&#160;<b>Other Events.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">On
May 10, 2022, the Company issued a press release announcing </span>positive safety data from its Phase 1, placebo-controlled, double-blind
multiple ascending dose (MAD) clinical trial of SYN-020 intestinal alkaline phosphatase (IAP). The Phase 1 MAD study enrolled 32 healthy
adult volunteers into four cohorts with SYN-020 administered orally in doses ranging from 5 mg to 75 mg twice daily for 14 days with a
follow-up evaluation at day 35. Each cohort included six subjects who received SYN-020 and two who received placebo. Analyses of preliminary
data demonstrated that SYN-020 maintained a favorable safety profile and was well-tolerated across all dose levels. There were a few treatment-related
adverse events, and all were mild (grade 1) and resolved without medical intervention. The most common adverse event, constipation, occurred
in three out of 24 subjects in the treatment arm and in one out of eight subjects in the placebo arm. No adverse event led to discontinuation
of the study drug and there were no serious adverse events.&#160;SYN-020 levels were below the limit of quantitation in all plasma samples
at all timepoints during the study.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
Number</b></span></td>
    <td style="vertical-align: top; width: 1%; padding-right: 0.8pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><a href="tm2215025d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.8pt"><a href="tm2215025d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by Synthetic Biologics, Inc., dated May 10, 2022</span></a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 10, 2022</span></td>
    <td colspan="3" style="padding-right: 2.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SYNTHETIC BIOLOGICS, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 3%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 5%; padding-right: 0.8pt">&#160;</td>
    <td style="width: 42%; padding-right: 0.8pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 1.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Steven A. Shallcross</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven A. Shallcross</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt">&#160;</td>
    <td style="padding-right: 0.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Chief Executive Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">and Chief Financial Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LW4d6GSXDhVxyhgi3hYXpbg1I60/eyTf0m5DDIGQnPPlCDERG1rrGhnOyzKHIzZtrRxCiVdkNBf0jmy7S8HPEm/aOlbGDesPzMgz6JnZdKH8fXA+tcUqhWgeyiSMJURJKhMo9iLo9YzMVVdonFY1KFNBwdSyRqe4Gz8c1ZsMNd2QdEK2mkwKchqN8gfiSMZwoKd6Ed8t5HkmgslQgdgwPdo+5mEdNbCqsfFZdkT/HXwB5GpJJA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2215025d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2215025d1_ex99-1img01.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Synthetic Biologics Reports
Positive Safety Data on SYN-020 Intestinal Alkaline Phosphatase </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>Phase 1 Multiple Ascending
Dose Clinical Trial</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>-Orally administered SYN-020
observed to be well tolerated across all doses in healthy volunteers-</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ROCKVILLE, MD &ndash; May 10, 2022 (GLOBE NEWSWIRE)
-- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases
in areas of high unmet need, today announced positive safety data from its Phase 1, placebo-controlled, double-blind multiple ascending
dose (MAD) clinical trial of SYN-020 intestinal alkaline phosphatase (IAP). The Phase 1 MAD study enrolled 32 healthy adult volunteers
into four cohorts with SYN-020 administered orally in doses ranging from 5 mg to 75 mg twice daily for 14 days with a follow-up evaluation
at day 35. Each cohort included six subjects who received SYN-020 and two who received placebo. Analyses of preliminary data demonstrated
that SYN-020 maintained a favorable safety profile and was well-tolerated across all dose levels. There were a few treatment-related adverse
events, and all were mild (grade 1) and resolved without medical intervention. The most common adverse event, constipation, occurred in
three out of 24 subjects in the treatment arm and in one out of eight subjects in the placebo arm. No adverse event led to discontinuation
of the study drug and there were no serious adverse events.&nbsp;SYN-020 levels were below the limit of quantitation in all plasma samples
at all timepoints during the study. Additional analyses, including fecal levels of SYN-020 and anti-drug antibody levels are on-going.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Both the previously reported Phase 1 single ascending
dose (SAD) study and the current MAD study are intended to support the development of SYN-020 in multiple clinical indications. The Company
is continuing to evaluate potential lead indications, which may include celiac disease, nonalcoholic fatty liver disease (NAFLD), and
radiation enteropathy as well as indications to treat and prevent metabolic and inflammatory disorders associated with aging. This latter
group of age-related clinical indications is supported by the Company&rsquo;s collaboration with Massachusetts General Hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;SYN-020 is a promising, versatile asset
that has the potential to become a multi-indication therapeutic capable of addressing a considerable market opportunity and unmet need
for innovative, new therapies targeting disorders stemming from gastrointestinal (GI) inflammation,&rdquo; said Steven A. Shallcross,
Chief Executive Officer of Synthetic Biologics. &ldquo;We will continue to explore the therapeutic potential of SYN-020 across indications
including celiac disease, NAFLD, age-related metabolic and inflammatory diseases. We are very encouraged by these positive Phase 1 results
and look forward to SYN-020&rsquo;s clinical advancement.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SYN-020 is a recombinant bovine IAP formulated
for oral delivery to the small intestine and designed to diminish fat absorption and intestinal inflammation, tighten the gut barrier
to mitigate &ldquo;leaky gut,&rdquo; and promote a healthy microbiome. Despite its broad therapeutic potential, a key hurdle to commercialization
has been the high cost of IAP manufacture. Synthetic Biologics has overcome this hurdle and has the ability to produce SYN-020 at a scale
and cost viable for clinical and commercial development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Synthetic Biologics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Synthetic Biologics, Inc. (NYSE American: SYN)
is a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need. The Company recently
consummated the acquisition of VCN Biosciences, S.L. (VCN), which is developing a new oncolytic adenovirus (OV) platform designed for
intravenous (IV), intravitreal and antitumoral delivery to trigger tumor cell death, improve access of co-administered cancer therapies
to the tumor, and promote a robust and sustained anti-tumor response by the patient&rsquo;s immune system. The Company's lead candidates
are: (1) VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor
stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment; (2) SYN-004 (ribaxamase) which
is designed to degrade certain commonly used intravenous (IV) beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent
(a) microbiome damage, (b) <I>Clostridioides difficile</I> infection (CDI), (c) overgrowth of pathogenic organisms, (d) the emergence
of antimicrobial resistance (AMR), and (e) acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT)
recipients, and (3) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions
and intended to treat both local GI and systemic diseases. For more information, please visit Synthetic Biologics' website at <U>www.syntheticbiologics.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified
by terminology such as &quot;may,&quot; &quot;should,&quot; &quot;potential,&quot; &quot;continue,&quot; &quot;expects,&quot; &quot;anticipates,&quot;
 &quot;intends,&quot; &quot;plans,&quot; &quot;believes,&quot; &quot;estimates,&quot; and similar expressions, and includes statements
regarding the Phase 1 SAD study and the current MAD study supporting the development of SYN-020 in multiple clinical indications,</I>
continuing to explore the therapeutic potential of SYN-020 across indications, including celiac disease, NAFLD, and age-related metabolic
and inflammatory diseases, and the continued development of SYN-020<I>. These forward-looking statements are based on management's expectations
and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult
to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied
by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include,
among others, Synthetic Biologics' ability to develop SYN-020 in multiple indications, including as a therapeutic for treatment of disorders
stemming from gastrointestinal (GI) inflammation, including celiac disease, NAFLD, and age-related metabolic and inflammatory diseases,
<FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Synthetic Biologics' and VCN's product candidates demonstrating
safety and effectiveness, as well as results that are consistent with prior results; the ability to initiate and complete clinical trials
on time and achieve the desired results and benefits; continuing clinical trial enrollment as expected; the ability to obtain regulatory
approval for commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating
to Synthetic Biologics' and VCN's ability to promote or commercialize their product candidates for the specific indications; acceptance
of product candidates in the marketplace and the successful development, marketing or sale of Synthetic Biologics' and VCN's products;
developments by competitors that render such products obsolete or non-competitive; Synthetic Biologics' and VCN's ability to maintain
license agreements;, the continued maintenance and growth of Synthetic Biologics' and VCN's patent estate; the ability to continue to
remain well financed;, and other factors described in Synthetic Biologics' Annual Report on Form 10-K for the year ended December 31,
2021 and its other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release
is provided only as of the date of this release, and Synthetic Biologics undertakes no obligation to update any forward-looking statements
contained in this release on account of new information, future events, or otherwise, except as required by law.</FONT></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chris Calabrese</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LifeSci Advisors, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ccalabres@lifesciadvisors.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1-917-680-5608</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>syn-20220510.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaqG2bOdzZR+6YkxtmB3bRm6Tywuu+t0/iR4Dyf2obED -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:syn="http://syntheticbiologics.com/20220510" elementFormDefault="qualified" targetNamespace="http://syntheticbiologics.com/20220510">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://syntheticbiologics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="syn-20220510_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="syn-20220510_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>syn-20220510_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>syn-20220510_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://syntheticbiologics.com/role/Cover" xlink:href="syn-20220510.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://syntheticbiologics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2215025d1_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2215025d1_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. /8# 2(  A$! Q$!_\0
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M:5IUM)>ZCJ=W;Z=I]G&5,EU?7LR6UK;@E@JA[B2-6E8%8E)E965"K?JEX/\
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MS,@U2PLC):WME,NXP7>F217,082MYFS:VW'_ -"SA7BB6>\1_1WXUX0XDP>
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M$5MC8<@B%H_G_P 7?MJ?LC?#CXM?\*D\0>._#F@^.;+6]+\.ZA-9>%-7;0M
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MK)*T$?QY&*BN5*RBVE=MMVE+WFVVVYZSDVVW*<G?4GHHHJAA1110 UQE2/Z
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M-\-_'VO^ /$7B[PK8:WX@^&'B&7Q)\/]2O%<S^%/$-UIIL)]5T[RY$1;B6Q
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M_P!9MDLY&FLHUN-B"5+"=C)9B=IUMV&^())\Q]G-A#$UI;VZ0PPP)%'#&MJ
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MOFOT0^*J6(BLIS_A?.,+=\];,89AP_BE%IJ].AE.'K89R3:;BYJ+2E'9I/\
MOK)/VA7A3B,)1_UAX!X^R;'02:I9;7R?B?"N3C:2EC,1C\CA".ZO5RK$:--1
MC.TJ?\GXU:5I8H$#--<2+#;0I%*TMU-(P2.&SC"EKR65R!'%;>;)(Q 12<@?
ML1^PA_P3@\8?$O6="^+?[0OA^]\,_"_3IUU/0? FL12V'B7X@2I&S0'6=.!B
MN="\)0RE+D6UT;;6M9>)'E%I&[P-^W7PJ_8F_9@^"5W'J7PT^#?@S0M8C&%U
MV[L[KQ!KP)4*736?$-YJE]%*=H+20RH7(.0"2U?3<=D4C,>8^<_<#H,9!10
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1*5=2^L57[:K40444519__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140071699126696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 10,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SYNTHETIC BIOLOGICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000894158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3808303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9605 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">417-4364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>tm2215025d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syn-20220510.xsd" xlink:type="simple"/>
    <context id="From2022-05-10to2022-05-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894158</identifier>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-10to2022-05-10">0000894158</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-10to2022-05-10">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-10to2022-05-10">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-10to2022-05-10">2022-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-10to2022-05-10">SYNTHETIC BIOLOGICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-10to2022-05-10">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-10to2022-05-10">001-12584</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-10to2022-05-10">13-3808303</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-10to2022-05-10">9605 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-05-10to2022-05-10">Suite 270</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-10to2022-05-10">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-10to2022-05-10">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-10to2022-05-10">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-10to2022-05-10">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-10to2022-05-10">417-4364</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-10to2022-05-10">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-10to2022-05-10">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-10to2022-05-10">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-10to2022-05-10">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-05-10to2022-05-10">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-10to2022-05-10">SYN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-10to2022-05-10">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-10to2022-05-10">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ 64JJ5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ 64JJ5 =!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !9
M2JI47'3CGN\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " !92JI4F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %E*JE0I7FK?
M5 0  -P0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " !92JI4GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2215025d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://syntheticbiologics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2215025d1_8k.htm">tm2215025d1_8k.htm</File>
    <File>syn-20220510.xsd</File>
    <File>syn-20220510_lab.xml</File>
    <File>syn-20220510_pre.xml</File>
    <File>tm2215025d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2215025d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2215025d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "syn-20220510_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syn-20220510_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "syn-20220510.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "syn",
   "nsuri": "http://syntheticbiologics.com/20220510",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2215025d1_8k.htm",
      "contextRef": "From2022-05-10to2022-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://syntheticbiologics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2215025d1_8k.htm",
      "contextRef": "From2022-05-10to2022-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-22-058009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-058009-xbrl.zip
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MG5LN )MM,#110&38G0%H5&)4J)&0>X/CEB=;S%^72=33;9A"MWA 1MM\Z*J
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M2N>A2$/L'DUG?UK_&:DH#PA<LQ7'<E';Y>MVS5)@)2RKRA4('185"Q9)$#C
MOG0BKAFJI*C4^EHIJV784B0MW14$5ENJ^EN)052\S9'1"+3JVV/S?[&/'H0Q
M DQVL,M<=P,VDWI7T-0$@4&',>-DI9(BI?4UV>'0A6WZ!P4;;X."3<^@8!/B
MH& S=%"P\3HH4+LNERD1;=3-.DTV&%@TL5/M&HP.RSHC%FE0N,#^P+:C#D&'
M&!^K;1;+KLE7"?!MX>%2?+"4%- Y6V^SRV:]X*9-% 0G7<Z,)3?+A? :8B35
M/MC8Q4E.XM+094(QC1*<UDLWVJZ>]X<X(V:@^1J>'GT8' TS:2!5AJDU%NO
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MLBR7Z^<Z@1FV@"D4,4J:&)6'@'ND!*?<<CG]Z.X@-2>BGG6='10T2E(8%H9
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M+N5H$^*399K4$1:"'Z%C+>@!+$,J_\!OH'<YXZR'NI)4<DE5\=GX]P1Q8-:
MBEI'L=J0*(S5X20]A>(C6*6K_90 ]WS48N"(=$>HR20]4UJ4*(CV6!+24XQ
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M>F2\U.0!+WKN%\9C%C2*G!S4H@*#7=W)!=36$1\ '!7<LR$S&TB;*N :OJX
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MW.]M5$)^667<D-)NJQ[WSTXK.:\40_>=:&W<AQ!9(2D^32>:9<7['IP8>Y=
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M  !S>6XM,C R,C U,3!?;&%B+GAM;%!+ 0(4 Q0    ( %E*JE13P*8-6P<
M -18   4              "  9T.  !S>6XM,C R,C U,3!?<')E+GAM;%!+
M 0(4 Q0    ( %E*JE148W:CM14  $)W   2              "  2H6  !T
M;3(R,34P,C5D,5\X:RYH=&U02P$"% ,4    " !92JI4U]/:8W$/  ";+P
M%@              @ $/+   =&TR,C$U,#(U9#%?97@Y.2TQ+FAT;5!+!08
1    !0 % $8!  "T.P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
